Araştırma Makalesi

Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq

Cilt: 6 Sayı: 4 1 Aralık 2016
  • Reem F Polse, Samira Y Yousif, Mahde Saleh Assafi
PDF İndir
EN

Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq

Abstract

Objectives: Uropathogenic Escherichia coli are the most important group of microorganisms responsible for urinary tract infection. A high percentage of uropathogenic E. coli over the world are detected to be ESBLs producers, which is now a problem that limits therapeutic options. The aim of this study is to determine the prevalence of ESBLs E. coli and study the prevalence of different ESBLs genotype patterns among the ESBLs producing isolates. Methods: One hundred and six uropathogenic E. coli isolates were analyzed for their ESBL production by molecular methods. Results: 55 (52%) isolates were detected as extended spectrum β-lactamases (ESBLs) producers. Based on the PCR results, all E. coli isolates possessed one or more ESBL gene. CTX-M type ESBL was the most dominant ESBL (87.2%) among the isolates. While those for TEM-type and SHV-type were 54.5% and 21.8% respectively. Six genotype patterns were detected (TEM, CTX-M, TEM+SHV, TEM+CTX-M, SHV+CTX-M and TEM+SHV+CTX-M). The genotype CTX-M was the most prevalent genotype (40%) followed by the genotype TEM+CTX-M combination (30.9%). The occurrences of the genotypes (TEM, TEM+SHV, SHV+CTX-M and TEM+SHV+CTX-M) were 7.3%, 5.5%, 5.4%, 10.9%, respectively. Conclusions: Control measures and education programs are necessary to avoid the uncontrollable use of β-lactam and cephalosporins in order to minimize the emergence of ESBLs producing E. coli. J Microbiol Infect Dis 2016;6(4): 163-167  

Keywords

Kaynakça

  1. 1. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, and Maselle SY. Antimicrobial resistance among producers and nonproducers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res Notes 2010;3:348.
  2. 2. French GL. Clinical impact and relevance of antibiotic resistance. Adv Drug Deliv Rev 2005; 57:1514-1527.
  3. 3. Queenan AM and Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007; 20:440-458.
  4. 4. Polse RF, Yousif SY, and Assafi MS. Prevalence and antimicrobial susceptibility patterns of uropathogenic E. coli among people in Zakho, Iraq. Int J Res Med Sci 2016; 4:1219-1223.
  5. 5. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-496.
  6. 6. CLSI, Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI-NCCLS document M100-S15. Clinical and laboratory standards institute, Wayne, PA. 2004.
  7. 7. Yun-Tae K, Kim TU, and Baik HS, Characterization of extended spectrum β-lactamase genotype TEM, SHV, and CTX-M producing Klebsiella pneumoniae isolated from clinical specimens in Korea. J Microbiol 2006;16:889-895.
  8. 8. Dhillon RH, Clark J. ESBLs: A clear and present danger? Crit Care Res Pract 2012;2012:625170.

Ayrıntılar

Birincil Dil

Türkçe

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Reem F Polse, Samira Y Yousif, Mahde Saleh Assafi Bu kişi benim

Yayımlanma Tarihi

1 Aralık 2016

Gönderilme Tarihi

1 Nisan 2016

Kabul Tarihi

16 Eylül 2016

Yayımlandığı Sayı

Yıl 2016 Cilt: 6 Sayı: 4

Kaynak Göster

APA
Mahde Saleh Assafi, R. F. P. S. Y. Y. (2016). Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq. Journal of Microbiology and Infectious Diseases, 6(4), 163-167. https://doi.org/10.5799/jmid.328863
AMA
1.Mahde Saleh Assafi RFPSYY. Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq. Journal of Microbiology and Infectious Diseases. 2016;6(4):163-167. doi:10.5799/jmid.328863
Chicago
Mahde Saleh Assafi, Reem F Polse, Samira Y Yousif,. 2016. “Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq”. Journal of Microbiology and Infectious Diseases 6 (4): 163-67. https://doi.org/10.5799/jmid.328863.
EndNote
Mahde Saleh Assafi RFPSYY (01 Aralık 2016) Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq. Journal of Microbiology and Infectious Diseases 6 4 163–167.
IEEE
[1]R. F. P. S. Y. Y. Mahde Saleh Assafi, “Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq”, Journal of Microbiology and Infectious Diseases, c. 6, sy 4, ss. 163–167, Ara. 2016, doi: 10.5799/jmid.328863.
ISNAD
Mahde Saleh Assafi, Reem F Polse, Samira Y Yousif,. “Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq”. Journal of Microbiology and Infectious Diseases 6/4 (01 Aralık 2016): 163-167. https://doi.org/10.5799/jmid.328863.
JAMA
1.Mahde Saleh Assafi RFPSYY. Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq. Journal of Microbiology and Infectious Diseases. 2016;6:163–167.
MLA
Mahde Saleh Assafi, Reem F Polse, Samira Y Yousif,. “Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq”. Journal of Microbiology and Infectious Diseases, c. 6, sy 4, Aralık 2016, ss. 163-7, doi:10.5799/jmid.328863.
Vancouver
1.Reem F Polse, Samira Y Yousif, Mahde Saleh Assafi. Prevalence and molecular characterization of extended spectrum beta-Lactamases-producing uropathogenic Escherichia coli isolated in Zakho, Iraq. Journal of Microbiology and Infectious Diseases. 01 Aralık 2016;6(4):163-7. doi:10.5799/jmid.328863

Cited By